Long-Term Safety of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
Long-Term Safety of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis David T. Rubin 1, Bruce A. C. Cree 2, Douglas C. Wolf 3, Olga Alekseeva 4, Lorna Charles 5, AnnKatrin Petersen 5, James K. Sheffield 5, Chun-Yen Cheng 5, Jon V. Riolo 5, Diego Silva 5, Fred D. […]